Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $20.5000 (-5.09%) ($20.5000 - $23.6000) on Wed. Jan. 13, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.88% (three month average) | RSI | 24 | Latest Price | $20.5000(-5.09%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -5.1% a day on average for past five trading days. | Weekly Trend | CAPR declines -12.7% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) SKYY(8%) ARKK(7%) EWI(7%) PEJ(7%) VT(7%) | Factors Impacting CAPR price | CAPR will decline at least -2.44% in a week (0% probabilities). VIXM(-5%) TLT(-5%) SLV(-3%) GLD(-3%) BND(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.44% (StdDev 4.88%) | Hourly BBV | 0 () | Intraday Trend | -6.4% | | | |
|
1 - 5 Day Possible Target | $-3.93(-119.17%) | Resistance Level | $29.08 | 5 Day Moving Average | $22.5(-8.89%) | 10 Day Moving Average | $25.76(-20.42%) | 20 Day Moving Average | $29.08(-29.5%) | To recent high | -55.4% | To recent low | 0% | Market Cap | $404m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |